Home/Filings/4/0001225208-22-008105
4//SEC Filing

WANG HUIMIN 4

Accession 0001225208-22-008105

CIK 0001099800other

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 7:44 PM ET

Size

8.3 KB

Accession

0001225208-22-008105

Insider Transaction Report

Form 4
Period: 2022-06-14
WANG HUIMIN
CVP, Japan & Intercontinental
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2022-06-143,67529,400 total
    Exercise: $35.20From: 2016-06-12Exp: 2023-05-11Common Stock (3,675 underlying)
  • Sale

    Common Stock

    2022-06-14$87.75/sh3,675$322,48199,336.802 total
  • Exercise/Conversion

    Common Stock

    2022-06-14$35.20/sh+3,675$129,348103,011.802 total
Footnotes (1)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0001204553

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 7:44 PM ET
Size
8.3 KB